top of page

Providing high quality reagents for 3D printing human tissue models 

OUR BIOINK TECHNOLOGY

new-bioprinter.png

Compatible with multiple bioprinters

new-cells.png

High cell viability post printing

Beta tested by industry leaders

white animals.png

Xeno-free

Reduces time and labor costs

Designed for use with fragile cells

Bioink Technology
Awads & Recogitin
AxB1_edited.jpg

AWARDS & RECOGNITION

MEET THE TEAM

stephanie1.jpg

Dr. Stephanie Willerth
~
CEO

  • LinkedIn

Dr. Willerth is a full professor of Biomedical Engineering who runs an active research group that investigates how to engineer neural tissue from pluripotent stem cells. Her research group has developed many types of biomaterial scaffolds for promoting the differentiation of induced pluripotent stem cells (iPSCs) into neural phenotypes for tissue engineering applications, such as screening the toxicity of drugs, learning about how tissues form during development and replacing dysfunctional tissues. She founded Axolotl Biosciences with the goal of bioprinting neural tissues easily accessible to scientists and engineering from a range of backgrounds.

Laura-Crop.jpg

Dr. Laura De La Vega
~
Co-Founder

  • LinkedIn

Dr. Laura De La Vega is a scientist and bioengineer who's passionate about basic, translational science and innovative technologies. She holds expertise in the fields of stem cells, biomaterials, and biotechnology involving the development of technological applications using biological systems. She completed her PhD at the University of Victoria where she developed novel techniques for engineering neural tissue under the direction of Dr. Willerth. Her goal in co-founding Axolotl Biosciences is to optimize bioinks for multiple bioprinting platforms and address customer needs within the 3D bioprinting industry.

Meet The Team
Our Supporters

SUPPORTED BY:

46fa9493-63e5-4187-81b9-3e62e6c5aa87.jpeg
MSFHR_logo.jpg
irap-750x459-removebg-preview.png
CTA_Boston_EN_edited.jpg
1200px-Natural_Sciences_and_Engineering_
BioTalent_Logo_CMYK_bilEF_NoTag-002-scal
ventureLAB Logo - full colour (1) (1).png
InnovateBC_Logo.png
AxB4.PNG

PUBLICATIONS

Publications
AxB4.PNG

PUBLICATIONS

3D printing of neural tissues derived from human induced pluripotent stem cells using a fibrin-based bioink

ACS Biomaterials Science and Engineering. 2018;5(1):234-43

E. Abelseth, L. Abelseth, L. De la Vega, S.T. Beyer, S.J.Wadsworth, S.M. Willerth

Bioprinting a novel glioblastoma tumor model using a fibrin based bioink for drug screening

Materials Today Chemistry. 2019, (12). 78-84

C. Lee, E. Abelseth, L. de la Vega, S.M. Willerth

3D bioprinting human induced pluripotent stem cell-derived neural tissues using a novel lab-on-a-printer technology

Applied Science. 2018. 2018, 8(2414). 1-13

L. De la Vega, D.A. Rosas Gómez, E. Abelseth, L. Abelseth, V.A. da Silva, S.M. Willerth

3D bioprinting pluripotent stem cell derived neural tissues using a novel fibrin bioink containing drug releasing microspheres

Frontiers in Bioengineering and Biotechnology. 2020, 8(57)

R. Sharma, I.P.M. Smits, L. De la Vega, C. Lee, S.M. Willerth

Novel N-cadherin antagonist causes glioblastoma cell death in a 3D bioprinted co-culture model

Biochemical and Biophysical Research Communications. 2020. 2020, 527(2),162-168

I.P.M. Smits, O.W. Blaschuk, S.M. Willerth

3D bioprinting human pluripotent stem cells and drug releasing microspheres to produce responsive neural tissue 

Advanced NanoBioMed Research. 2000077. 1-16.

L. De la Vega, L. Abelseth, R. Sharma, J. Triviño-Paredes, M. Restan, S.M. Willerth

Physical and Mechanical Characterization of Fibrin-Based Bioprinted Constructs Containing Drug-Releasing Microspheres for Neural Tissue Engineering Applications

Frontiers in Bioengineering and Biotechnology. 2020, 8(57)

R. Sharma, IR. Kirsch, K. P. Valente, M. Restan Perez, S.M. Willerth

3D Bioprinting Mesenchymal Stem Cell-Derived Neural Tissues Using a Fibrin-Based Bioink

Biomolecules 2021, 11(8), 1250

M. Restan Pe, R. Sharma, N.Z. Masri, S.M. Willerth

Social Media
AxB1_edited_edited_edited_edited_edited_edited.jpg

CHECK OUT OUR SOCIAL MEDIA

bottom of page